The BOOG 2013-08 trial evaluates whether SLNB can be safely omitted for patients with clinically T1-2N0 treated with ...

International study finds AI detects pancreatic cancer on CT more accurately than radiologists, offering earlier diagnosis ...

Tom Nolan reviews this week’s research Whenever flu hits the headlines, as it has this winter, attention inevitably turns to the flu vaccine. Might a higher dose be more effective in older adults? A ...

Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting ...

Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase 3 development Reported positive prelimi ...

Outlook Therapeutics ( (OTLK) ) has shared an update.

A new £50 million initiative aims to cut the length of time novel medicines spend in clinical trials, enabling patients to benefit from new treatments much sooner.

(HealthDay News) — Zoliflodacin is noninferior to ceftriaxone plus azithromycin for the treatment of uncomplicated urogenital gonorrhea, according to a study published online Dec. 11 in The Lancet.

Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the discovery, development, production and commercialization of innovative therapeutics for rare diseases with significant unmet ...

Being a doctor grants you the privilege of helping fellow human beings. As rewarding and respectable as the medical profession is, the pathway to becoming a doctor is trying and tedious.

Introduction Many neonatal deaths are avoidable using existing low-cost evidence-based interventions. This study evaluated ...

In your view, what global challenges does each of the four global initiatives address? How do you understand the intrinsic ...